WebMD Announces Exploration Of Strategic Alternatives

Go back to WebMD Announces Exploration Of Strategic Alternatives

WebMD (WBMD) PT Raised to $55 at Mizuho Securities Following 4Q Results, Strategic Options

February 17, 2017 5:45 AM EST

Mizuho analyst Neil Doshi reiterates Neutral rating and raises price target on WebMd Health Corp. (NASDAQ: WBMD) to $55 (from $52), noting a disappointing outlook and back-end loaded growth, as the company reported 2016 fourth quarter results in-line with estimates, while exploring strategic alternatives.

Doshi... More

WebMD Health (WBMD) Tops Q4 EPS by 7c; Guides Q1, FY17 Revs Below Views

February 16, 2017 4:04 PM EST

WebMD Health (NASDAQ: WBMD) reported Q4 EPS of $0.73, $0.07 better than the analyst estimate of $0.66. Revenue for the quarter came in at $207.5 million versus the consensus estimate of $206.99 million.

GUIDANCE:

WebMD Health sees Q1 revs of $151 million to $154 million versus the... More